| Role of Acetaldehyde in the Development of Oral Cancer (NCT05973656) | Masonic Cancer Center, University of Minnesota | 2022-07-08 |
| Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102 (NCT07527975) | Rocket Pharmaceuticals Inc. | 2022-02-01 |
| Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab (NCT04784052) | Porteus, Matthew, MD | 2021-12-07 |
| Eltrombopag for Treatment of Fanconi Anemia (NCT06045052) | Julian Sevilla | 2020-12-02 |
| Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures (NCT04232085) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-12 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders (NCT03579875) | Masonic Cancer Center, University of Minnesota | 2018-11-13 |
| Eltrombopag for People With Fanconi Anemia (NCT03206086) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-11-02 |
| A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia (NCT03600909) | Memorial Sloan Kettering Cancer Center | 2018-05-15 |
| Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia (NCT03476330) | Children's Hospital Medical Center, Cincinnati | 2018-05-08 |
| Pilot Study of Metformin for Patients With Fanconi Anemia (NCT03398824) | Boston Children's Hospital | 2018-03-29 |
| Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients (NCT03609840) | University of California, San Francisco | 2017-05-24 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor (NCT02678533) | Assistance Publique - Hôpitaux de Paris | 2017-02-10 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study (NCT03733249) | Bellicum Pharmaceuticals | 2017-01-01 |
| Investigation of the Genetics of Hematologic Diseases (NCT02720679) | St. Jude Children's Research Hospital | 2016-06-17 |
| Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A (NCT03157804) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2016-01-07 |
| HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (NCT02143830) | Children's Hospital Medical Center, Cincinnati | 2014-04-01 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1 (NCT02931071) | Hospital Universitari Vall d'Hebron Research Institute | 2013-09-01 |
| Quercetin in Children With Fanconi Anemia; a Pilot Study (NCT01720147) | Children's Hospital Medical Center, Cincinnati | 2012-07-01 |
| Gene Therapy for Fanconi Anemia (NCT01331018) | Fred Hutchinson Cancer Center | 2012-02-22 |
| Unrelated HSCT in Patients With Fanconi Anemia (NCT02127905) | Neena Kapoor, M.D. | 2011-03-01 |
| Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (NCT01316549) | University of California, San Francisco | 2011-01-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita (NCT01001598) | Boston Children's Hospital | 2009-11-01 |
| Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01146210) | Children's Oncology Group | 2009-05-01 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders (NCT00856388) | Roswell Park Cancer Institute | 2009-01-14 |
| Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer (NCT00542373) | M.D. Anderson Cancer Center | 2007-08-27 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 (NCT00479115) | Children's Hospital Medical Center, Cincinnati | 2007-05-01 |
| Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia (NCT00453388) | Fred Hutchinson Cancer Center | 2007-02-01 |
| Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment (NCT00499070) | University Hospital Freiburg | 2007-01-01 |
| TBI Dose De-escalation for Fanconi Anemia (NCT00352976) | Masonic Cancer Center, University of Minnesota | 2006-05-18 |
| Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia (NCT00965666) | Children's Hospital Medical Center, Cincinnati | 2005-10-01 |
| Tissue Sample Collection From Patients With Fanconi Anemia (NCT00899522) | OHSU Knight Cancer Institute | 2005-08-01 |
| Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia (NCT00272857) | Boston Children's Hospital | 2004-08-01 |
| Blood Cell Collection for Future Use in Individuals With Fanconi Anemia (NCT00271089) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-08-01 |
| Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia (NCT00243399) | Children's Hospital Medical Center, Cincinnati | 2004-07-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases (NCT01019876) | Columbia University | 2002-09-01 |
| Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia (NCT00258427) | Masonic Cancer Center, University of Minnesota | 2002-03-26 |
| Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT (NCT00586274) | Baylor College of Medicine | 2002-03-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Cancer in Inherited Bone Marrow Failure Syndromes (NCT00027274) | National Cancer Institute (NCI) | 2001-11-28 |
| Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia (NCT00590460) | Baylor College of Medicine | 2001-07-01 |
| Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708) | University of California, San Francisco | 2000-08-01 |
| Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia (NCT00630253) | Masonic Cancer Center, University of Minnesota | 2000-02-17 |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia (NCT00093743) | Fred Hutchinson Cancer Center | 2000-01-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia (NCT00317876) | Fred Hutchinson Cancer Center | 1998-06-01 |
| Cord Blood Stem Cell Transplantation Study (COBLT) (NCT00000603) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma (NCT00900055) | OHSU Knight Cancer Institute | 1975-06-01 |
| Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts (NCT06731036) | University of Florida | |
| Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents (NCT01995305) | Xiaofan Zhu | |